NCT06733233 2024-12-13
A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer
Guangzhou Women and Children's Medical Center
Phase 2 Not yet recruiting